Have Insiders Sold Icosavax Shares Recently?

We'd be surprised if Icosavax, Inc. (NASDAQ:ICVX) shareholders haven't noticed that the Chief Scientific Officer, Douglas Holtzman, recently sold US$219k worth of stock at US$11.14 per share. However, the silver lining is that the sale only reduced their total holding by 7.4%, so we're hesitant to read anything much into it, on its own.

Check out our latest analysis for Icosavax

Icosavax Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by Independent Chair Mark McDade for US$300k worth of shares, at about US$7.10 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$8.67. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

Icosavax is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Icosavax Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Icosavax insiders own about US$21m worth of shares. That equates to 6.0% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

What Might The Insider Transactions At Icosavax Tell Us?

An insider sold Icosavax shares recently, but they didn't buy any. But we take heart from prior transactions. We like that insiders own a fair amount of the company. So we're happy enough to look past some selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To help with this, we've discovered 6 warning signs (2 shouldn't be ignored!) that you ought to be aware of before buying any shares in Icosavax.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.